Context Therapeutics Inc.

Biotechnology • Healthcare • Philadelphia, PA, United States • CNTX (NCM)

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance

Yahoo Finance • Oct 8

Guggenheim Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq

Nasdaq • Sep 18

Context Therapeutics (NASDAQ: CNTX) Highlights CT-95 and CT-202 at SITC Meeting - Stock Titan

Stock Titan • Nov 7

Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results - GlobeNewswire

GlobeNewswire • Nov 5

Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7% - What's Next? - MarketBeat

MarketBeat • Dec 16

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Context Therapeutics Inc. had layoffs?

No layoff events have been recorded for Context Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Context Therapeutics Inc. have?

Context Therapeutics Inc. has approximately 12 employees.

What industry is Context Therapeutics Inc. in?

Context Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Context Therapeutics Inc. a publicly traded company?

Yes, Context Therapeutics Inc. is publicly traded under the ticker symbol CNTX on the NCM. The company has a market capitalization of approximately $0.11 billion.

Where is Context Therapeutics Inc. headquartered?

Context Therapeutics Inc. is headquartered in Philadelphia, PA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.